The central allegations within this litigation is that the drugs are linked to gastroparesis, a condition that paralyzes stomach muscles
Current status Ozempic : FDA approved for adults with type 2 diabetes Wegovy : semaglutide product FDA approved for chronic weight management in eligible patients Retatrutide : not FDA approved as of March 25, 2026 FDA has also warned consumers about illegally sold unapproved GLP-1-related products containing retatrutide
However, important considerations include: Oral semaglutide (Rybelsus): The SmPC for Rybelsus specifically states it must be taken on an empty stomach with water only, followed by at least 30 minutes before any food, drink or other oral medicines (including magnesium supplements)
Guided treatment improves outcome of patients with enterocutaneous fistulas
If you need help deciding which medication is right for you, our providers will discuss your individual needs and help you determine the right choice
Can I use my HSA to pay for GLP-1